Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres

There were approximately 10 million tuberculosis (TB) cases in 2020, of which 500,000 were drug-resistant. Only one third of drug-resistant TB cases were diagnosed and enrolled on appropriate treatment, an issue partly driven by a lack of rapid, accurate drug-susceptibility testing (DST) tools deplo...

Descripción completa

Detalles Bibliográficos
Autores principales: MacLean, Emily Lai-Ho, Miotto, Paolo, González Angulo, Lice, Chiacchiaretta, Matteo, Walker, Timothy M., Casenghi, Martina, Rodrigues, Camilla, Rodwell, Timothy C., Supply, Philip, André, Emmanuel, Kohli, Mikashmi, Ruhwald, Morten, Cirillo, Daniela Maria, Ismail, Nazir, Zignol, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065236/
https://www.ncbi.nlm.nih.gov/pubmed/37000774
http://dx.doi.org/10.1371/journal.pgph.0001754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065236/
https://www.ncbi.nlm.nih.gov/pubmed/37000774
http://dx.doi.org/10.1371/journal.pgph.0001754

Ejemplares similares